
- Volume 0 0
ASPIRIN UNDER STUDY FOR ANTICANCER EFFECTS
Researchers are currently studying the possibleanticancer effects of aspirin. Aspirinblocks cyclooxygenase (COX), which helpsrestrict the blood supply to tumors, therebylimiting tumor growth. The studies of aspirininvolved exposing blood vessel cells to aspirinor COX-2 inhibitors like celecoxib. Aspirin athigh doses caused death of the blood vesselcells. This effect was not seen with standarddoses of aspirin or with COX-2 inhibitors.Investigators plan to continue studying theunderlying mechanism of aspirin's effect inorder to identify new targets for cancer drugs.
Dr. Garrett is a clinical pharmacistpractitioner at Cornerstone Health Carein High Point, NC.
Articles in this issue
almost 19 years ago
Making Dry Eye Disappearalmost 19 years ago
What You Need to Know About Cold Soresalmost 19 years ago
Help for Chapped Lipsalmost 19 years ago
can you READ these Rxs?almost 19 years ago
compounding HOTLINEalmost 19 years ago
A Review of Federal Legislation Affecting Pharmacy Practicealmost 19 years ago
Strategies and Tools for Promoting Medication Adherencealmost 19 years ago
The Role of the Pharmacist in Screening for CVD Riskalmost 19 years ago
Drug Diversion in Vermontalmost 19 years ago
Volunteerism Is the Heart of RESPy WinnerNewsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.















































































































































































































